Richard K. Burdick

Decision Sciences · Social Sciences

24h-index2.4kcitations166works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Scientific Measurement and Uncertainty Evaluation(56), Biosimilars and Bioanalytical Methods(54), Statistical Methods in Clinical Trials(27), Optimal Experimental Design Methods(23), Advanced Statistical Methods and Models(22)

Publications166 total

Degrees-of-Freedom Approximations for Conditional-Mean Inference in Random-Lot Stability Analysis
arXiv (Cornell University)·2026Open Access
Degrees-of-Freedom Approximations for Conditional-Mean Inference in Random-Lot Stability Analysis
arXiv (Cornell University)·2026Open Access
Planning Split-Apheresis Designs for Demonstrating Comparability of Cellular and Gene Therapy Products
The AAPS Journal·2024
Comparison of Analytical Procedures in Method Transfer and Bridging Experiments
The AAPS Journal·2023· 3 cited
Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
The Lancet Diabetes & Endocrinology·2021· 211 cited
Statistical Considerations for Comparative Assessment of Quality Attributes
Statistics in Biopharmaceutical Research·2020· 4 cited
The Goldilocks Challenge—Controlling Uncertainty When Setting Product Specifications
PDA Journal of Pharmaceutical Science and Technology·2020
Contributors
Elsevier eBooks·2019
The rigor of statistical analysis in assessing biophysical data
Elsevier eBooks·2019
Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product
Figshare·2019Open Access
Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product
Figshare·2019Open Access
Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product
Figshare·2019Open Access
Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product
Figshare·2019Open Access
Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product
Figshare·2019Open Access
Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product
Figshare·2019Open Access
Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product
Figshare·2019Open Access
Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product
Figshare·2019Open Access
Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product
Figshare·2019Open Access
PDA Biosimilars Workshop Report (September 27—28, 2018)—Getting It Right the First Time for Biosimilar Marketing Applications
PDA Journal of Pharmaceutical Science and Technology·2019· 1 cited
Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product
Figshare·2019Open Access
page 1 of 9Next →

Frequent Co-authors

Franklin A. Graybill(14), Douglas C. Montgomery(5), Tai‐Fang C. Lu(5), Connie M. Borror(4), Donald W. Jackson(4), Janet E. Keith(4), Naitee Ting(4), Jorge Quiroz(4), Nancy J. Birch(3), Greg A. Larsen(2), Lorraine Daniels(2), Bruce J. Walker(2), Leslie Sidor(2), Rongde Gui(2), Ioanna Gouni‐Berthold(1), Veronica J. Alexander(1), Qingqing Yang(1), Eunju Hurh(1), Elisabeth Steinhagen‐Thiessen(1), Patrick M. Moriarty(1)